Heart Health
Senolytics, Gene Therapy and Lifestyle Can Slow Cardiovascular Aging
A 2025 review maps the molecular drivers of cardiac aging and evaluates drugs, CRISPR, stem cells, and lifestyle as countermeasures.
Research Paper
May 11, 2026 0
3 articles
A 2025 review maps the molecular drivers of cardiac aging and evaluates drugs, CRISPR, stem cells, and lifestyle as countermeasures.
Dive deep into the molecular mechanisms of vascular aging and explore cutting-edge interventions โ from senolytic therapies and nitric oxide restoration to exercise-induced remodeling and emerging pharmacological approaches โ that are redefining what's possible in cardiovascular longevity.
Scientists identify GSDME as a master switch driving abdominal aortic aneurysms through vascular aging, opening new treatment paths.